Apollo Endosurgery To Report Second Quarter 2017 Financial Results On August 1, 2017
Published: Jul 26, 2017
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its second quarter 2017 financial results on Tuesday, August 1, 2017 after the U.S. stock markets close.
Apollo will hold a conference call on Tuesday, August 1, 2017 at 3:30 p.m. CT / 4:30 p.m. ET to discuss the results. The dial-in numbers are (877) 548-7914 for domestic callers and (719) 457-6931 for international callers. The conference ID number is 2382032.
A telephonic replay of the call will be available until August 8, 2017. The replay dial-in numbers are (844)-512-2921 for domestic callers and (412) 317-6671 for international callers. Please use the replay conference ID number 2382032.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today.
Apollo’s common stock is traded on the NASDAQ Global Market under the symbol "APEN." For more information regarding Apollo Endosurgery, go to: www.apolloendo.com
Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
Chief Financial Officer
The Ruth Group
Lee Roth or Zack Kubow, 646-536-7000